Nordwand Advisors’s Vivos Therapeutics VVOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48K Buy
+10,000
New +$3K ﹤0.01% 145

Other funds holding VVOS

Nordwand Advisors's VVOS Position: Q3 2026 in Review

Nordwand Advisors opened a new position in Vivos Therapeutics (VVOS) in Q3 2026: 10,000 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #145 among its holdings.

27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • Nordwand Advisors held 10,000 shares of Vivos Therapeutics worth $1.48K as of Q3 2026.
  • Vivos Therapeutics was a new Nordwand Advisors position in Q3 2026.
  • Vivos Therapeutics made up ﹤0.01% of Nordwand Advisors's portfolio in Q3 2026, its #145 holding.
  • 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on Nordwand Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.